Richard is a partner at Goodwin Procter and corporate counsel to Humatics. As a lawyer, consultant and entrepreneur, Richard has extensive experience in establishing new companies, negotiating and closing venture capital financings, in-licensing technologies, and developing and implementing corporate and business development strategies. He also has a successful track record in structuring, negotiating, and documenting strategic deals with both public and private companies. Previously a partner with WilmerHale, Richard has previously worked in the biotech industry, serving as a legal advisor and business consultant to numerous biotech companies. As principal at R.A. Hoffman Consulting, he provided entrepreneurs and early-stage biotechnology, medical device and healthcare information companies with advice on corporate and business development strategies and tactics. Prior to his consulting work, Richard was vice president of finance and business development at Hybridon (now Idera Pharmaceuticals), and later served in a similar capacity at biotech company Avitech. Richard received degrees from Columbia Law School (JD), the Wharton School at the University of Pennsylvania (MBA) and Harvard College (BA, magna cum laude).